Roivant Sciences Ltd
ROIV
Market Cap$9.05B
Close$
$-3.69
132.8% downside
Current Fair Value
132.8% downsideOvervalued by 132.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.05 Billion |
|---|---|
| Enterprise Value | $2.89 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $5.73 |
| Beta | 1.0 |
| Outstanding Shares | 805,846,006 |
| Avg 30 Day Volume | 3,839,711 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 2.03 |
|---|---|
| PEG | -0.13 |
| Price to Sales | - |
| Price to Book Ratio | 1.6 |
| Enterprise Value to Revenue | 23.41 |
| Enterprise Value to EBIT | -2.75 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
ESG Score
No data